NCT04332835View on ClinicalTrials.gov

Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

August 8, 2020

Primary Completion Date

October 31, 2020

Study Completion Date

November 15, 2020

Conditions
CoronavirusCoronavirus Infection
Interventions
DRUG

Plasma

Day 1: CP-COVID19, 250 milliliters. Day 2: CP-COVID19, 250 milliliters.

DRUG

Standard Therapy

Standard therapy defined by institutional protocol.

Trial Locations (1)

11100

Universidad del Rosario, Bogota

Sponsors

Collaborators (1)

CES University
All Listed Sponsors
collaborator

Fundación Universitaria de Ciencias de la Salud

OTHER

collaborator

CES University

OTHER

collaborator

Instituto Distrital de Ciencia Biotecnología e Innovacion en Salud

UNKNOWN

lead

Universidad del Rosario

OTHER